PolarCool sign first Rugby deal in the UK with Scarlets Rugby
PolarCool AB (publ) has entered into an agreement with the United Rugby Championship team, Scarlets, for the use of the PolarCap® System. The agreement marks an important breakthrough for PolarCool in UK Rugby.
PolarCool develops and markets the product PolarCap® which alleviates the effects of concussion. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, and handball.
The agreement with the Scarlets means that PolarCap® will be used by the team during the start of the United Rugby Championship in an initial trial period, with the aim to transition into a two-year commercial agreement following the trial. The deal marks a strategic introduction for PolarCap® within UK Rugby and the United Rugby Championship.
Rugby is one of PolarCool's most important markets, as the sport has more than 180,000 clubs and 6.6 million players globally. The concussion rate in rugby is high putting rugby players at a larger risk of injury compared to athletes in other sports. PolarCool are currently in discussions with several rugby clubs both in France and England, where the interest in reducing the effects of the injury is high.
PolarCool's CEO Erik Andersson comments:
-In our ongoing establishment on the British market, it is now gratifying that we have received our first agreement within UK Rugby. We notice that the wish for solutions regarding the problems with head injuries in the rugby world is large. With this first and more to come agreements we envisage an increased awareness of the possibility of treatment with PolarCap® System and thereby an accelerating establishment in this market aw well as also in other sports on the UK.
The Scarlets are one of the four professional Welsh rugby union teams and are based in Llanelli, Wales, UK. They have a rich history of success and are known for producing some of the best rugby players in the world. They play in the United Rugby Championship and the European Rugby Champions Cup.
For more information
Erik Andersson – CEO PolarCool AB (publ)
+46 - 738 60 57 00
E-mail: erik.andersson@polarcool.se
About PolarCool AB (publ)
PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.